Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Autologous chondrocyte implant - TETEC

Next Previous
Drug Profile

Autologous chondrocyte implant - TETEC

Alternative Names: Jelrix; Matrix-assisted autologous chondrocyte transplantation - TETEC; N3D; NOVOCART® 3D Plus; NOVOCART® Inject

Latest Information Update: 08 Aug 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator TETEC
  • Developer Aesculap Biologics; TETEC
  • Class Cell therapies
  • Mechanism of Action Cartilage replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Cartilage disorders

Most Recent Events

  • 24 Jul 2025 The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) received a negative opinion of Autologous chondrocyte implant for the treatment of cartilage disorders in the European Union
  • 29 Sep 2020 Phase-III development for Cartilage disorders is ongoing in USA (NCT03219307)
  • 30 Nov 2018 Aesculap Biologics initiates enrolment in a phase III trial for Cartilage disorders in USA (NCT03219307)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top